Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 13
Review
Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 26,400 | Dovepress* | 14,837+ | 1,988 | 16,825 | |
| PubMed Central* | 11,563 | 1,354 | 12,917 | ||
| Totals | 26,400 | 3,342 | 29,742 | ||
| *Since 14 July 2017 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 16 | 1 | 0 | 0 | 4 | 11 |
View citations on PubMed Central and Google Scholar